Ellipsys Medical, Inc. today announced that the Ellipsys® Vascular Access System will once again be commercially available, with initial availability anticipated in mid-2026. The announcement marks the planned reintroduction of the minimally invasive technology to clinicians and patients following a period of limited market availability. The Ellipsys System, previously available...
Latest News
Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.
We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.
We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.
Definition medical devices.
Medical Device Industry News | Latest Developments, Breakthroughs & Future Outlook
Latest News and Developments
Genesys Spine Announces Launch of the SIros-X™ System for Sacroiliac Joint Fusion and Pelvic Fixation of Pedicle Screw Constructs
Inaugural case performed by spine surgeon Dr. Scott L. Parker highlights the system's strength, versatility, and precision for supporting multi-level spinal constructs
Cartessa Aesthetics and Classys Introduce QUADESSY, a Faster, Safer and More Versatile Microneedling Radiofrequency Platform
Quadessy delivers multi-layer skin remodeling through a unique tip and dual-depth design
Clinical Trials
Complement Therapeutics Announces First Patient Dosed with CTx001 in the Phase I/II Opti-GAIN Study for Geographic Atrophy Secondary to AMD
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD
Innovative Medical Equipment, LLC Highlights Published VA Clinical Study on Thermal Therapy and Pain Treatment Utilization
The study, published in The March 2026 edition of Federal Practitioner, reported an association between thermal therapy use and reduced opioid and benzodiazepine utilization, as well as lower healthcare utilization in the patient population.
Results from PARADIGM Phase 2b Trial of PrimeC in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity Published in JAMA Neurology
The Journal of the American Medical Association (JAMA Neurology) publication highlights consistent clinical and biomarker findings from NeuroSense PARADIGM Phase 2b trial in ALS, including slower functional decline, reduced risk of ALS-related complications, and modulation of disease-relevant biomarkers
Biotechnology News
iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids
Joint initiative with Rosebud Biosciences, Kantify, and funded by Incite will identify and quantify off-target toxicities in chemotherapy patients
Primerdesign Partners with Origin Sciences to Create Novel Rectal Mucosal Extraction Workflow
Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases
AnalytiChem Launches New Legionella Testing Selective Agar Plate
Redipor® Legionella agar plate range - specifically designed to support the detection and enumeration of Legionella in water samples
Mergers & Acquisitions
Funding
Nordic Biotech Company Pila Pharma Raises Capital for New International Obesity Study
September 12, 2024
According to According to Pila Pharma, the capital raised will support the study with the objective to assess the molecule’s safety in increased dosages, as well as to expand on the number of study participants to determine, though empirical statistical calculations, whether the molecule has potential as part of a new tablet-based obesity treatment., the capital raised will support the study with the objective to assess the molecule’s safety in increased dosages, as well as to expand on the number of study participants to determine, though empirical statistical calculations, whether the molecule has potential as part of a new tablet-based obesity treatment.
Synaptogenix Announces $5.0 Million Financing
September 11, 2024
“We are pleased to benefit from the support of our committed long-term investors in this financing,” said Dr. Alan Tuchman, Chief Executive Officer of Synaptogenix. “This capital enhances our ability to be both strategic and opportunistic as we explore potential acquisitions or fund research on innovative assets, all with the goal of driving growth and maximizing value for our shareholders.”
Industry Expert Bylines
Honeywell Q&A: How Technology Improves Remote Patient Care During Cold & Flu Season
October 31, 2023
With cold and flu season approaching, more sick patients will be in hospitals in the coming months. Mr. Rizkallah discusses several challenges hospitals will face during this cold and flu season and how Honeywell’s real-time health monitoring system can improve patient outcomes. Read on.
A Strategic, Compliant Response to No Surprise Act Supported by Medical Billing Partnership | By Christine Cooper, CEO of aequum LLC
October 27, 2023
More than a year ago, the U.S. healthcare system marked a turning point with the passage of the No Surprises Act (NSA). Signed into federal law after extensive negotiation between health plan insurers and providers, the NSA took full effect at the start of 2022 to protect the rights of patients and health plan participants from receiving excessive balance bills for certain emergency services and from out-of-network providers at in-network facilities.
The Evolution of Mixed-Modes Patient-Reported Outcomes Guidance: A Journey Towards Evidence-Based Practices in BYOD | By: Dr. Jill Platko, Vice President of Scientific Services at Suvoda
October 23, 2023
Collecting patient-reported outcome (PRO) data is an integral function of clinical research, providing the patient perspective that enriches the evaluation of treatment effectiveness. Historically, patient-reported outcomes measurement (PROM) was performed predominantly with paper-based assessments. However, over the past two decades, there has been a notable paradigm shift towards the electronic collection of data.
FDA Medical Device Updates
Market Reports
Executives
WorldQuant Foundry Appoints Dr Christopher Mason as Senior Healthcare Advisor to Spearhead AI-Driven Healthcare Innovation
In his new role, Dr. Mason will collaborate with the WorldQuant Foundry ecosystem of entrepreneurs and data scientists in an effort to identify and develop transformative opportunities in the healthcare sector.
January 17, 2025
Chris Freeman Appointed Strategic Advisor at Cyted Health
“The expertise Chris Freeman brings in leading large-scale commercialization strategies is unparalleled,” said Dr Marcel Gehrung, Cyted Health’s CEO and Co-Founder. “Cyted Health’s transformative technology is already modernising diagnostic pathways across the UK. Chris’ insights will be instrumental as we pursue significant opportunities ahead of us in the US and globally.”
January 15, 2025
Advancements In Imaging
Amstelland Hospital in the Netherlands Selects Sectra’s Subscription Model for Enterprise Imaging to Improve Efficiency & Patient Care
“Partnering with Amstelland and providing them with Sectra One makes me proud. Our subscription model offers them the flexibility to scale their imaging solution, ensuring that they can continue to provide high-quality care to their patients while adapting to the changing healthcare landscape,” says Peter Osinga, Managing Director, Sectra Benelux and DACH.
June 27, 2023
Techsomed Announces Field Evaluation of its Image Guided Ablation Therapy Software Using GE HealthCare LOGIQ™ Ultrasound Systems at Top US Clinical Sites
Techsomed’s BioTrace platform, currently in advanced clinical evaluation, is a significant advancement in Image Guided Ablation Therapy. The technology leverages standard imaging—such as ultrasound (US) along with computed tomography (CT) or magnetic resonance imaging (MRI).
June 26, 2023
GE HealthCare Advances PET/MR Capabilities with AIR Technologies
Jie Xue, President and CEO of MR at GE HealthCare. “Our latest PET/MR technology will directly impact the most challenging diseases, such as prostate cancer and Alzheimer’s Disease. These diseases require precise and comprehensive imaging for accurate diagnosis, treatment planning, and therapy monitoring. We are excited to see SIGNA PET/MR AIR addressing these challenges and fulfilling our vision of providing access to advanced, personalized care.”
June 23, 2023
Hospitals In the News
Non-Profit News
Healthcare: Understanding the Business Side of the Industry and Its Implications
A/B Testing in Healthcare Software Development: Why Your Business Needs It Today
As any company in the healthcare software industry will attest to, businesses often have to test the waters of their market or audience before committing to any major design decisions.
October 17, 2023
From Language to Life: The Vital Role of Medical Translators in Global Healthcare
This article will explain how medical translation services effectively change global healthcare with their transformative role.
October 17, 2023
How Outsourcing Data Entry Services Elevates Healthcare Efficiency
Discover the power of LinkedIn data mining for boosting business success. Learn key insights and strategies in this informative guide.
October 17, 2023
The Key Traits Needed by Healthcare Leaders and How You Can Develop Them in Yourself
Healthcare is a dynamic and demanding field that requires exceptional leadership at every level. Whether you’re a healthcare professional aspiring to a leadership role or
October 12, 2023
